MENU
+Compare
KURA
Stock ticker: NASDAQ
AS OF
Jan 14, 04:59 PM (EDT)
Price
$7.24
Change
-$0.00 (-0.00%)
Capitalization
564.56M

KURA Kura Oncology Forecast, Technical & Fundamental Analysis

a provider of biopharmaceutical services

Industry Biotechnology
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for KURA with price predictions
Jan 08, 2025

KURA in upward trend: price expected to rise as it breaks its lower Bollinger Band on January 08, 2025

KURA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 49 cases where KURA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KURA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KURA entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.332) is normal, around the industry mean (15.808). P/E Ratio (0.000) is within average values for comparable stocks, (88.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.850). KURA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (261.317).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. KURA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KURA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KURA is expected to report earnings to fall 10.00% to -56 cents per share on February 20

Kura Oncology KURA Stock Earnings Reports
Q4'24
Est.
$-0.57
Q3'24
Est.
$-0.63
Q2'24
Beat
by $0.04
Q1'24
Missed
by $0.04
Q4'23
Est.
$-0.55
The last earnings report on November 07 showed earnings per share of -62 cents, meeting the estimate of -62 cents. With 1.03M shares outstanding, the current market capitalization sits at 564.56M.
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12730 High Bluff Drive
Phone
+1 858 500-8800
Employees
142
Web
https://www.kuraoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIKJX16.170.17
+1.06%
Fidelity Advisor Real Estate Z
SCVIX36.310.37
+1.03%
Allspring Small Company Value Admin
MFRJX57.420.12
+0.21%
MFS Research R4
MXYKX5.27N/A
N/A
Empower T. Rowe Price Mid Cp Gr Instl
HEMIX8.93-0.12
-1.33%
Janus Henderson Emerging Markets I

KURA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with PYXS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-1.09%
PYXS - KURA
44%
Loosely correlated
-1.29%
AXON - KURA
41%
Loosely correlated
-0.23%
PSTX - KURA
35%
Loosely correlated
N/A
ZYME - KURA
35%
Loosely correlated
+5.60%
EVAX - KURA
34%
Loosely correlated
-5.56%
More